Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 2: Themed issue: Cardiometabolic
Submit an article Journal homepage
654
Views
12
CrossRef citations to date
0
Altmetric
Diabetes

Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control

Carlos I. AlatorreEli Lilly and Company, Indianapolis, IN, USA; Correspondence[email protected]
,
Byron J. HoogwerfEli Lilly and Company, Indianapolis, IN, USA;
,
Mark A. DeegEli Lilly and Company, Indianapolis, IN, USA;
,
David R. NelsonEli Lilly and Company, Indianapolis, IN, USA;
,
Theresa M. HunterEli Lilly and Company, Indianapolis, IN, USA;
,
Wee Teck NgEli Lilly and Company, Lilly NUS Center for Clinical Pharmacology, Singapore
&
Mark D. RekhterEli Lilly and Company, Indianapolis, IN, USA;
show all
Pages 337-343 | Received 11 Jul 2017, Accepted 23 Oct 2017, Published online: 24 Nov 2017

References

  • Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 2014;383:1068-83
  • Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89
  • Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59
  • Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72
  • Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39
  • Kelly TN, Bazzano LA, Fonseca VA, et al. Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med 2009;151:394-403
  • Bailey CJ, Day C. Glycaemic memory. Br J Diabetes Vasc Dis 2008;8:242-7
  • Whelton PK, Barzilay J, Cushman WC, et al. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Arch Intern Med 2005;165:1401-9
  • Barzilay JI, Davis BR, Pressel SL, et al. Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT diabetes extension study. Circ Cardiovasc Qual Outcomes 2012;5:153-62
  • Gerstein HC. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE. Diabetes Metab Res Rev 2002;18(Suppl3):S82-S85
  • Nicolucci A, Standl E. Antiplatelet therapy for every diabetic person? Diabetes Care 2011;34(Suppl2):S150-S154
  • Riddle MC, Ambrosius WT, Brillon DJ, et al. Epidemiological relationships between A1c and all-cause mortality during a median 3.4- year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010;33:983-90
  • Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015;44:827-36
  • Soedamah-Muthu SS, Fuller JH, Mulnier HE, et al. High risk of cardiovascular disease in patients with type 1 diabetes in the UK.: a cohort study using the general practice research database. Diabetes Care 2006;29:798-804
  • Kiri VA. Programming challenges of sampling controls to cases from the dynamic risk sets in nested case–control studies. Pharm Program 2012;5:29-33
  • Khan NF, Perera R, Harper S, et al. Adaptation and validation of the Charlson Index for READ/OXMIS coded databases. BMC Fam Pract 2010;11:1
  • Gelman A, Rubin DB. Markov chain Monte Carlo methods in biostatiscs. Stat Methods Med Res 1996;5:339-55
  • Wilke T, Mueller S, Groth A, et al. Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2015;14:14
  • Paul SK, Klein K, Thorsted BL, et al. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol 2015;14:100
  • Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet 2010;375:481-9
  • Palta P, Huang ES, Kalyani RR, et al. Hemoglobin A1c and mortality in older adults with and without diabetes: results from the National Health and Nutrition Examination Surveys (1988–2011). Diabetes Care 2017;40:453-60
  • St Onge EL, Motycka CA, Miller SA. A review of cardiovascular risks associated with medications used to treat type-2 diabetes mellitus. Pharm Therapeut 2009;34:368-78
  • Panicker GK, Karnard DR, Salvo V, et al. Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. JAPI 2012;60:56-61
  • Nussbaum C, Klinke A, Adam M, et al. Myeloperoxidase: A leukocyte-derived protagonist of inflammation and cardiovascuar disease. Antioxidants Redox Signaling 2013;18:692-713
  • Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2015;38:1777-803
  • Lorber D. Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes MetabSyndr Obes 2014;7:169-83
  • British Medical Journal Editorial. Scotland and London have the widest health gap. BMJ 2004;328:0-b

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.